Baipharm
ChemLinked
Market
Chemical
Food
Cosmetic
BaiPharm
Agrochemical
Japan
LOG IN
SIGN UP
LOG IN
Home
News
Insights
Database
Events
Webinars
Offline Events
Services
Home
News
Insights
Database
Drug Catalog
ChP Standards
Events
Webinars
Offline Events
Services
Search
Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
All
Interpretation
Report
Q&A
All
Interpretation
Report
Q&A
Topic
Regulation
CDE Guideline
Law & Regulation
Pharmacopoeia
Reference Listed Drug (RLD)
Hot topic
Bioequivalence (BE)
Clinical Trial
CMC
CRO
DMF
Drug Registration
GCP
GMP
License in/out
MAH
Marketing Approval
New Drug
Pharmacovigilance
Post-market
Priority Review and Approval
Policy
Medical Insurance
NRDL
Volume-Based Procurement
Product
API
Biological Product
Biosimilar
Generic Drug
Innovative Drug
OTC Drug
Apply
Cancel
Clinical Trial
Q&A
China CDE Q&A | Drug Registration Applications & Clinical Trials
Aug 08, 2022
INTERPRETATION
Leading Contract Research Organizations (CRO) in China
May 31, 2022
INTERPRETATION
Generic Drug Application (ANDA) in China
May 18, 2022
Q&A
FAQ on Rare Disease Drugs (Orphan Drugs) in China
Apr 07, 2022
REPORT
China Drug Evaluation Report 2020-Reform of Drug Review & Approval System
Aug 27, 2021
